CFH rs3741775: Understanding Your Genetic Risk for AMD
The rs3741775 variant is a genetic change located within the CFH gene, which provides instructions for making a protein that regulates the immune system. This specific variant is recognized as a genetic risk factor associated with the development of age-related macular degeneration (AMD).
What each genotype means
Typical retinal risk profile
You carry two copies of the common C allele at this CFH regulatory site. Current research provides limited evidence linking this baseline genotype to altered complement activity or elevated macular degeneration risk on its own. Because scientific findings for this specific non-coding site remain modest and often reflect broader regional gene patterns, this genotype alone does not indicate significant vision risk.
Carried by approximately 45% to 50% of individuals of European descent, with varying frequencies across other global ancestries.
Slightly altered complement regulatory profile
You carry one copy of the T alternate allele alongside one standard C allele. In preliminary association studies, this non-coding variant has shown weak statistical connections to complement regulation and retinal outcomes, though current published evidence is limited and inconclusive. Having this single variant copy has not been demonstrated to cause age-related macular changes independently.
Found in roughly 40% to 45% of individuals in European populations, where the minor allele frequency is around 30%.
Altered complement regulatory profile
You carry two copies of the T allele at this CFH regulatory marker. While some research notes modest statistical associations with complement system activity and retinal health in age-related maculopathy, the scientific evidence specifically isolating this non-coding variant remains limited. Carrying this genotype does not mean you will develop vision complications, as retinal health depends heavily on age, lifestyle, and other genetic factors.
Carried by approximately 8% to 10% of individuals of European ancestry and occurs at lower rates in certain non-European groups.
What is rs3741775?
The rs3741775 variant is a single-nucleotide polymorphism (SNP) located within the CFH gene locus. In genetics, a SNP represents a variation at a single position in the DNA sequence among individuals. This particular variant is classified as a regulatory SNP, meaning it is situated in a region of the genome that helps control how much of a specific protein is produced or when that production occurs. Because it is not necessarily changing the protein structure itself, its primary impact is thought to be on the expression levels of the complement factor H protein. Researchers study this variant to understand how subtle changes in non-coding DNA can influence complex biological pathways, particularly those involved in inflammation and immune responses within the eye.
The Role of the CFH Gene
The CFH gene encodes the complement factor H protein, a critical component of the body's complement system. The complement system is a part of the innate immune response that helps clear pathogens and damaged cells. Factor H acts as a regulator, preventing the complement system from becoming overactive and damaging healthy tissues. When the complement system is not properly regulated, it can lead to chronic, low-level inflammation. In the context of the eye, this dysregulation is believed to contribute to the accumulation of deposits known as drusen under the retina. These deposits are a hallmark of age-related macular degeneration (AMD), a condition that affects central vision. By maintaining the balance of the immune response, the CFH gene plays a protective role in ocular health.
Research and Evidence
Scientific research has identified the CFH locus as a major site for genetic risk factors related to AMD. Studies, including genome-wide association studies (GWAS), have consistently linked variants in this region to an increased likelihood of developing the condition. The evidence for rs3741775 specifically is often described as limited or part of a broader set of linked variants within the CFH gene cluster. While many studies confirm that the CFH region is strongly associated with AMD, the specific contribution of individual SNPs can be complex due to linkage disequilibrium, where multiple variants are inherited together. It is important to note that genetic risk is only one piece of the puzzle; environmental factors such as smoking, diet, and age also play significant roles in the progression of macular health issues.
What You Can Do With This Information
Understanding your genetic profile regarding rs3741775 does not provide a medical diagnosis or a guarantee of future health outcomes. Because AMD is a multifactorial condition, having a risk-associated genotype does not mean you will develop the disease, nor does the absence of such a variant guarantee protection. If you are concerned about your vision or family history of eye disease, the most effective step is to schedule a comprehensive eye examination with an ophthalmologist or optometrist. They can perform clinical assessments that are far more predictive of your current eye health than genetic testing alone. Always discuss any genetic information with a qualified healthcare provider who can interpret these results within the context of your overall health, lifestyle, and clinical history.
How common is this variant?
The minor allele frequency for rs3741775 is approximately 0.30 in European populations, making it a relatively common variant in that ancestry group.
Frequently asked questions
Does having the rs3741775 variant mean I will get AMD?
No, having this variant does not mean you will develop AMD. Genetic variants are risk factors, not diagnostic markers, and many people with this variant never develop the condition.
Is there a genetic test for AMD?
While genetic testing can identify variants like rs3741775, it is not a standard diagnostic tool for AMD. Clinical eye exams are the primary method for detecting and monitoring macular health.
Can I change my genetic risk for AMD?
You cannot change your DNA, but you can manage modifiable risk factors. Maintaining a healthy diet, avoiding smoking, and getting regular eye exams are recommended strategies for supporting long-term eye health.
How does CFH affect my eyes?
The CFH gene helps regulate the immune system's complement pathway. When this regulation is impaired, it may lead to inflammation in the retina, which is associated with the development of AMD.
Sources & further reading
Educational information only, last refreshed 10/23/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs3741775?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in CFH
This variant in the complement factor H gene is associated with altered regulation of the alternative complement pathway and increased susceptibility to age-related macular degeneration.
Intronic single nucleotide variant in the CFH region associated with susceptibility to age-related macular degeneration (AMD).
Common variant in the CFH locus strongly associated with risk of age-related macular degeneration (AMD).
Genomic marker in CFH frequently co-inherited in haplotypes modulating risk of late-stage visual loss from macular degeneration.
Intronic marker in CFH forming critical susceptibility haplotypes for choroidal neovascularization and macular atrophy.
Intergenic/intronic variant within the CFH cluster contributing to phenotypic variation in retinal complement activation.